TELA Bio, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2025: USD -1.41

TELA Bio, Inc. EPS (Diluted) is USD -1.41 for the Trailing 12 Months (TTM) ending March 31, 2025, a -15.57% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • TELA Bio, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -1.67, a -41.81% change year over year.
  • TELA Bio, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -2.87, a 12.55% change year over year.
  • TELA Bio, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -2.55, a 18.06% change year over year.
  • TELA Bio, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -2.16, a -26.78% change year over year.
Key Data
Date EPS (Diluted) Shares (Diluted, Weighted) Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses